triamcinolone acetonide has been researched along with Gouty Arthritis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, K; Gnanasakthy, A; Hirsch, JD; Lale, R; Sarkin, AJ | 1 |
| Arulmani, U; De Meulemeester, M; Murphy, V; Pikhlak, A; Richard, D; Sallstig, P; Schlesinger, N; So, A; Yücel, AE | 1 |
| Alloway, JA; Nashel, DJ; Siegel, LB | 1 |
| Alloway, JA; Hoogland, YT; Moriarty, MJ; Nashel, DJ | 1 |
3 trial(s) available for triamcinolone acetonide and Gouty Arthritis
| Article | Year |
|---|---|
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Gouty; Dose-Response Relationship, Drug; Humans; Inflammation; Male; Middle Aged; Pain; Quality of Life; Single-Blind Method; Triamcinolone Acetonide; Young Adult | 2011 |
Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis.
Topics: Acute Disease; Adrenocorticotropic Hormone; Aged; Arthritis, Gouty; Humans; Injections, Intramuscular; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide | 1994 |
Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Arthritis, Gouty; Humans; Indomethacin; Injections, Intramuscular; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide | 1993 |
1 other study(ies) available for triamcinolone acetonide and Gouty Arthritis
| Article | Year |
|---|---|
Efficacy of Canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Gouty; Female; Humans; Interleukin-1beta; Male; Middle Aged; Patient Outcome Assessment; Retrospective Studies; Triamcinolone Acetonide | 2014 |